HKD 1.11
(-4.31%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 145.09 Million USD | 22.77% |
2022 | 118.18 Million USD | 104.3% |
2021 | 57.85 Million USD | 42.41% |
2020 | 40.62 Million USD | 94.35% |
2019 | 20.9 Million USD | 136.39% |
2018 | 8.84 Million USD | -17.13% |
2017 | 10.67 Million USD | 37.91% |
2016 | 7.73 Million USD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q2 | 96.02 Million USD | 0.0% |
2023 Q2 | 115.33 Million USD | 0.0% |
2023 Q4 | 145.09 Million USD | 0.0% |
2023 FY | 145.09 Million USD | 22.77% |
2022 Q4 | 118.18 Million USD | 0.0% |
2022 FY | 118.18 Million USD | 104.3% |
2022 Q2 | 67.34 Million USD | 0.0% |
2021 Q4 | 57.85 Million USD | 0.0% |
2021 FY | 57.85 Million USD | 42.41% |
2021 Q2 | 45.17 Million USD | 0.0% |
2020 Q2 | 38.38 Million USD | 0.0% |
2020 Q4 | 40.62 Million USD | 0.0% |
2020 FY | 40.62 Million USD | 94.35% |
2019 FY | 20.9 Million USD | 136.39% |
2019 Q2 | 19.54 Million USD | 0.0% |
2019 Q4 | 20.9 Million USD | 0.0% |
2018 FY | 8.84 Million USD | -17.13% |
2018 Q4 | 8.84 Million USD | 0.0% |
2017 FY | 10.67 Million USD | 37.91% |
2016 FY | 7.73 Million USD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Uni-Bio Science Group Limited | 52.86 Million HKD | -174.457% |
CK Life Sciences Int'l., (Holdings) Inc. | 5.93 Billion HKD | 97.554% |